Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New tool helps doctors prioritize preventive care for each patient

NCT ID NCT05463887

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a decision tool that gives doctors personalized recommendations for preventive care based on each patient's risk factors. About 721 patients and 60 primary care providers took part. Half of the providers used the tool with some patients, while the other half continued with usual care. The goal was to see if the tool helped improve quality-adjusted life expectancy and use of preventive services.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
decision tool for preventive care recommendations
What this could lead to
If successful, this could help doctors and patients make better choices about which preventive services to focus on, potentially improving health and quality of life.
What could go wrong
This is a completed study testing a decision tool, not a treatment. The tool may not lead to meaningful changes in health outcomes, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

721 people

The number who actually took part.

Started

Aug 2022

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Provider eligibility criteria. Any attending physician, nurse practitioner or physician assistant practicing in internal medicine or family medicine. Patient eligibility criteria. This study define 2 types of patients, "eligible" patients and "high-priority" patients. "Eligible" patients are a broadly-defined group of patients of the intervention arm providers, for whom the providers will be able to access individualized preventive care recommendations. Eligible patients are subject to a waiver of informed consent. "High-priority" patients are a more narrowly-defined subset of eligible patients, who will be contacted by the study team for follow-up. Eligible patients will have the following inclusion criteria: 1. A provider assigned to the intervention arm of the RCT is the patient's primary care physician (PCP) of record in the EHR. 2. Aged 40-75 years. High-priority patients are defined as eligible patients who also meet all of the following inclusion criteria: 1. A modifiable lifestyle factor with a large impact on quality-adjusted life expectancy, assessed by ≥1 of the following: 1. current smoker 2. BMI ≥30.0 kg/m\^2 3. BP ≥140/90 mmHg 4. 10-year ASCVD risk ≥10% 5. HbA1c ≥9% 6. alcohol/week \>4.2 oz (98 g) for female or \>8.4 oz (196 g) for male 2. Eligible for a high number of preventive services, assessed by ≥3 of the following. Factor(s) used to satisfy criteria 1 also count toward satisfying criteria 2: 1. current smoker 2. BMI ≥27.0 kg/m\^2 3. systolic BP \>130 mmHg 4. 10-year ASCVD risk ≥7.5% 5. HbA1c ≥7.5% 6. alcohol/week \>4.2 oz (98 g) for female or \>8.4 oz (196 g) for male 7. Overdue or due soon for colorectal cancer screening, as of date that study team confirms "high-priority" eligibility criteria 8. Overdue or due soon for lung cancer screening, as of date that study team confirms "high-priority" eligibility criteria 9. Overdue for breast cancer screening for ≥1 year, as of date that study team confirms "high-priority" eligibility criteria 10. Overdue for osteoporosis screening for ≥1 year, as of date that study team confirms "high-priority" eligibility criteria 3. Ongoing primary care in the health system, defined as ≥2 visits with a primary care provider in the prior 730 days. 1. The term "primary care provider" is defined as an attending physician, nurse practitioner or physician assistant in the Department of Internal Medicine or Department of Family Medicine with an established patient panel. 2. The term "visit" is defined as an in-person or virtual visit encounter. 4. An eligible encounter with the patient's primary care physician (PCP) of record in the EHR. "Eligible encounter" is defined as follows: 1. An annual wellness visit (sometimes called a physical) with scheduled length of 40 minutes, or for some practice sites or departments, 30 minutes. These encounters typically focus on preventive care and are more likely to allow enough time to engage in shared decision-making. 2. For patients without an annual wellness visit in the prior 2 years, a visit with scheduled length at least 30 minutes, or a shorter length directly related to at least one service relevant to the research study (e.g., the EHR notes field indicates that a patient is scheduled for a follow-up of hypertension). Eligible patients have the following exclusion criteria, defined as ≥1 of the following: 1. Cancer in the past 3 years (other than non-melanoma skin) 2. Diagnosis of alcohol abuse in past 3 years 3. History of myocardial infarction 4. History of stroke 5. End-stage renal disease 6. Moderate-severe congestive heart failure (moderate-severe may be ignored if needed to facilitate automatic data extraction) 7. Moderate-severe chronic obstructive pulmonary disease (moderate-severe may be ignored if needed to facilitate automatic data extraction) 8. Other comorbidity with limited life expectancy, in the opinion of ≥2 members of the study team. 9. Inability to communicate or limited communication (speaking, reading, writing) in the English language. In addition to the above, high-priority eligible patients also have the following exclusion criteria, defined as ≥1 of the following: 1. Known current pregnancy. 2. Known acute care need that is likely to limit time available for discussion of preventive care. 3. The first primary care encounter since a hospitalization, surgery or emergency department utilization. There will be no exclusion from the study on the basis of race or ethnicity.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Decision support techniques are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cleveland Clinic

    Cleveland, Ohio, 44195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.